Video Latest - ecancer

ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib

Dr Giorgio Scagliotti - University of Turin, Turin, Italy

9 Oct 2016

Phase I results of a novel FGFR inhibitor

Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland

9 Oct 2016

Metabolomics: Reversing drug resistance

Dr Olivier Pardo - Imperial College London, London, UK

14 Sep 2016

Developing new models in SCLC

Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK

14 Sep 2016

Future of imaging in lung cancer

Prof Tony Ng - King's College London, London, UK

14 Sep 2016

ß1 integrins and DNA repair for radiosensitization of head and neck cancer

Dr Nils Cordes - Center for Radiation Research in Oncology, Dresden, Germany

13 Jul 2016

Cancer organoids

Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands

5 Jul 2016

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

29 Jun 2016

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

16 Jun 2016

Targeted genome editing in haematopoeitic stem cells

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy

11 Jun 2016

A microRNA driver of B-cell leukaemia

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy

11 Jun 2016

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients

Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France

11 Jun 2016

Video